跳到主要內容

Childs John W 的 Form 4/A 修正申報

修正

Veradermics, Inc(MANE),2026/2/27 申報

申報編號
0001027035-26-000004
申報時間
2026/2/27
交易日
2026/2/5
申報延遲
22 天
10b5-1 計畫
沒有勾選
原始申報日
2026/2/5

這份申報列了 1 筆非衍生性交易。沿用原件裡沒有重述的 7 筆交易。公開市場買進合計 $500.0 萬。交易後 22 天申報。

這份修正申報重述了 0001628280-26-005906(2026/2/5 申報)的一部分,沒有重述的交易仍然有效,列在下面。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Childs John WCIK 0001027035董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/2/5Common StockP買進取得+294,117$17.00+$4,999,989294,117間接

沿用原件的交易

這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。

來自 0001628280-26-005906(2026/2/5 申報)。

非衍生性證券(表 I)

沿用 0001628280-26-005906 的非衍生性證券交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/2/5Common StockC轉換取得+480,269–F1–480,269間接
2026/2/5Common StockC轉換取得+906,862–F3–1,387,131間接
2026/2/5Common StockC轉換取得+520,758–F4–1,907,889間接

衍生性證券(表 II)

沿用 0001628280-26-005906 的衍生性證券交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/2/5Common StockC轉換處分−480,269–F1–0間接
2026/2/5Common StockC轉換處分−906,862–F3–0間接
2026/2/5Common StockC轉換處分−520,758–F4–0間接
2026/2/3Common StockA公司授予取得+51,525$0.00$051,525直接

原件的附註

這幾筆交易的價格在原件上引用的附註。

F1

On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

表 I 有 1 筆、表 II 有 1 筆交易的價格引用這則附註。

F3

On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

表 I 有 1 筆、表 II 有 1 筆交易的價格引用這則附註。

F4

On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

表 I 有 1 筆、表 II 有 1 筆交易的價格引用這則附註。

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on February 5, 2026 (Original Form 4). The Original Form 4 inadvertently misstated that 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P. However, as reflected in this amendment, 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through the John W. Childs 2013 Revocable Trust, and no shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P.

F2

Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)